Although it started with “investment in joints” – as Adonis Georgiadis said in 2018 – the medical cannabis market aspires to develop into the new trend of the business scene.
The Minister of Development regretted that quip, as he admitted at yesterday’s inauguration of the Tikun Olam unit in Εxamilia Corinthia, giving credit to the pioneer Nikos Karanikas, advisor to the then Prime Minister Alexis Tsipras.
For his part, Mr. Karanikas, who played a leading role in paving the way for the legalization of the production and sale of medicinal cannabis in Greece, returned the compliments with emotion, while he told OT that “Adonis [Georgiadis] did what Xanthos [former SYRIZA minister] did not » referring to the improvements of the legislative framework.
Vassilis Milionis, known from the scandal of Energa – Hellas Power, was added to the list of “misunderstood”, related to the medicinal cannabis market in Greece, who was acquitted. He is said to be involved in Tikun Olam.
In fact, Adonis Georgiadis personally addressed Mr. Milionis, saying that he has had a difficult time and that he was unfairly criticized.
The slow maturation
The goals for the new market are particularly lofty, with many expressing the certainty that in the medium term it can reach 350 million euros per year, which is the turnover of the developed market of Israel.
However, for now growth is stable but relatively slow.
First-ever medicinal cannabis production plant opens in Greece
In particular, only two companies so far have managed to complete their investments up to commercial operation and obtain a production license.
In addition to the Israeli company Tikun Olam in Corinth, an investment that exceeded 40 million euros, a smaller unit has also been inaugurated, in Kilkis, with a budget of 6.5 million euros. It is Hellenic Dynamic, of Greek-Indian interests, which was listed on the London Stock Exchange a month ago through a “shell company”.
At the same time, according to the latest data available from the General Secretariat of Industry, there are 135 approvals for the establishment of units for the cultivation, processing, and production of finished medicinal cannabis products.
Despite this, the investments worth more than 2 billion euros, which will create 11,000 new jobs, as it appears from the plans that have been submitted to the Ministry of Development over the last 5 years, are not proceeding at a fast pace.
In particular, most permit requests, namely 33, concern the Region of Central Greece, 27 have been given to the Region of Central Macedonia with the most in the Prefecture of Klikis, 24 to the Region of Thessaly, 18 to the Region of Peloponnese, 15 to the Region of Western Greece and 5 in the Region of Western Macedonia.
In the Regions of Eastern Macedonia – Thrace, Epirus and Crete, 4 licenses have been given, while 2 in the Region of Attica and 1 in the Region of the South Aegean, specifically in the Cyclades.
The European medical cannabis market is predicted to grow at an annual rate of 21.96% in the period 2022 – 2027 and from 4.96 billion dollars in 2022 it will reach 13.37 billion dollars in 2027.
Globally, this market is estimated to reach $44.2 billion in 2022.
12 products with two providers
The first of a total of 12 products ( double line prescription as for opioid dispensation) medicinal cannabis products will be launched on the Greek market by Tikun Olam this September, with the company currently in pilot production at 20-30% of its capacity.
It is noted that currently only nutritional supplements have been released.
The production capacity of the factory in Corinth, which is among the most modern in Europe in its category, amounts to 10 tons per year.
In addition to the Greek market, the company also aims for export activity mainly in Europe.
It recently entered into two strategic partnerships with the pharmaceutical companies Farmaserve Hellas and Lavipharm, which have undertaken the distribution and marketing of a total of 12 codes in Greece.
The products will be distributed under different names by the two pharmaceutical companies.
As mentioned by Nikos Beis, managing director of Tikun Europe, it took five years of hard work to complete this important investment, which will offer multiple benefits, both to patients and to the local and national economy.
He particularly focused on the benefits that the new investment will create for cancer and kidney pain, as well as for patients with multiple sclerosis and others diseases. In addition, in the current phase, laboratory tests are being carried out and the effectiveness of cannabis products is tested in a number of other diseases such as epilepsy, autism, Chron’s disease and others.
Latest News
Which Islands Will Have Italians Flocking to Greece this Summer?
Well-known Italian travel magazine details reasons why Skopelos, Naxos and Astypalaia are the go-to summer destinations for Italians
Antentokounmpo 5th Highest Paid Athlete in World
The basketball player rakes in 111 million dollars per year, between his salary at the Bucks and endorsements from big brands like Amazon, Nike and Pepsi
Greek FM Gerapetritis: Need to Immediately End Gaza Hostilities
Gerapetritis added that a humanitarian crisis was transpiring in Gaza, with the concerns now being spillover in the wider Middle East.
ETC Report: Greece 3rd Most Popular Destination for Europeans
Italy and Spain are tied as the top destinations, each attracting 8% of travelers
Greece Battles EC to Protect Rice Industry and Public Health
Together with several other EU countries, Greece successfully blocked the European Commission's proposal to increase allowable levels of a banned pesticide commonly found in rice imported from southeast Asia
Eurostat: 3.2% Annual Inflation in Greece in April
The data shows that Greece ranks seventh in overall inflation within the eurozone and second in food inflation
Intrum’s 2024 Report Unveils Greek Businesses Embrace Digitalization for Growth
Looking ahead, over 40% of businesses prioritize development for 2024, with 65% recognizing the potential of digital business models as sustainable investments
IOBE: Mild Drop in April Business Confidence Index (BCI) in Greece
The positive balance of expectations for employment witnessed a marginal decline, while the index for production forecasts also recorded a mild drop
Greek PM Mitsotakis Calls on EU to Intervene Over Multinationals’ Pricing Policy
Speaking about price fairness, the Prime Minister emphasized, "Europe should also mean similar or uniform prices for the products sold by our multinational corporations.
Greenhouse Gas Emissions: 4% Decrease in EU, 0.3% Rise in Greece in Q4 2023
The EU's GDP remained stable with a marginal 0.2% increase in fourth quarter of 2023